Local Study of Akatinol Memantine in VaD in Russia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The study evaluates the clinical efficacy and safety of Akatinol Memantine 20 mg (single‐doses) vs. Akatinol Memantine 10 mg (double‐doses) in patients suffering from moderate and moderately severe vascular dementia.
Epistemonikos ID: a245e6ec44f4d662c62f3b0db9de62dad14d4b9e
First added on: May 22, 2024